1 / 24

NHS Community Pharmacy Contractual Framework

NHS Community Pharmacy Contractual Framework. The New Medicine Service (NMS). BLPC. New Medicine Service. It’s all about helping patients to get the most from their newly prescribed medicine Based on proof of concept research Advanced service (time limited to March 2013)

tyanne
Download Presentation

NHS Community Pharmacy Contractual Framework

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. NHS Community Pharmacy Contractual Framework The New Medicine Service (NMS) BLPC

  2. New Medicine Service • It’s all about helpingpatients to get the most from their newly prescribed medicine • Based on proof of concept research • Advanced service (time limited to March 2013) • Service will continue if it has demonstrated value to the NHS • Provision commenced 1st October 2011

  3. Benefits • PSNC and NHS Employers envisage that the successful implementation of NMS will: • improve patient adherence • increase patient engagement with their condition and medicines • reduce medicines wastage • reduce hospital admissions due to adverse events from medicines • lead to increased Yellow Card reporting • receive positive assessment from patients • improve the evidence base on the effectiveness of the service • support the development of outcome and/or quality measures for community pharmacy

  4. Funding • Up to £55m in both 2011/12 and 2012/13 • 2011/12 – implementation payment (£750) and target payments • 2012/13 – target payments • Target payments depend on the achievement of activity thresholds which are related to prescription volume

  5. Funding – target payments 2011/12

  6. NMS – outline service spec • Three stage process • Patient engagement (day 0) • Intervention (approx. day 14) • Follow up (approx. day 28) • Opportunity to provide healthy living advice at each stage Make sure you read the service spec before providing NMS!

  7. NMS – Patient engagement • Follows the prescribing of a new medicine for: • Asthma or COPD • Diabetes (Type 2) • Antiplatelet / Anticoagulant therapy • Hypertension • Apply professional discretion where a formulation change occurs • Recruitment by pharmacy or via referral • Dispense script and provide advice (as part of Dispensing service) List of medicines at www.psnc.org.uk/nms

  8. NMS – Patient engagement • Provide patient with information on the service • Patient leaflet text – use of this text is not mandatory • Collect written patient consent • Agree a method and time for the intervention (in 7-14 days)

  9. NMS – Intervention • Intervention typically day 7 – 14 • Face to face in a consultation area or over the phone • Semi-structured interview technique to: • assess adherence • identify problems • identify the patient’s need for further information and support Make sure you are aware of the limitations of telephone consultations

  10. NMS – Intervention • Pharmacist provides advice and support • agrees follow up • agrees solution(s) • refers to GP (only where absolutely necessary) • Make a record of the discussion using the standard dataset • An NMS worksheet has been published to help you make notes during the discussion You can use PharmaBase to make your records of the discussion

  11. NMS – Follow up • Follow up typically between 14 and 21 days after the Intervention • Face to face in a consultation area or over the phone • Semi-structured interview technique to: • assess adherence • identify problems • identify the patient’s need for further information and support The Interview Schedule has been developed to prompt a thorough conversation with the patient

  12. NMS – Follow up • Pharmacist provides advice and support • Patient adherent • Patient non-adherent • refer to GP (using nationally agreed NMS Feedback form) • provide more advice and support • Make a record of the discussion using the standard dataset • An NMS worksheet has been published to help you make notes during the discussion Only refer to the GP where absolutely necessary

  13. MURs and NMS • Patients are not usually eligible for an MUR within 6 months of receiving the NMS, unless in the pharmacist’s professional opinion the patient will benefit from an MUR • A note of the reason for carrying out an MUR within 6 months should be made on the patient’s record • There is no limit on the number of NMS a patient can receive in a year

  14. DNAs and completed NMS • If a patient • does not attend the intervention or follow up • cannot be contacted on the phone at the agreed time The pharmacy must attempt to contact them to rearrange the appointment • The NMS is only ‘completed’ in certain circumstances • Only competed NMS can be claimed for

  15. DNAs and completed NMS

  16. DNAs and completed NMS

  17. Knowledge & skills for NMS • Pharmacists must complete and sign the NMS – self-assessment of readiness for community pharmacists • There is no absolute requirement for training before providing NMS… • …but pharmacists must ensure they have the requisite knowledge Make sure you record your NMS related learning in your GPhC CPD record

  18. Data capture and reporting to the PCT • A standard dataset has been developed for NMS • This supports data capture in a standardised manner, to support evaluation of the service • A standard report can be requested by the PCT on a quarterly basis PharmaBase will collate your NMS data and produce the quarterly PCT report

  19. PharmaBase support • The NMS module in PharmaBase supports contractors to provide the NMS service, including the following functionality: • patient registration • printing consent forms • scheduling interventions and follow ups using a pharmacy calendar (which can also be used to manage appointments for other pharmacy services) • printing a patient information leaflet and appointment reminder • creating a task list of patient reminders to be provided prior to appointments • recording the mandatory dataset for the intervention and follow up • creating NMS Feedback forms to refer patients back to their GP practice • an ‘NMS dashboard’ to allow the pharmacy team to keep track of their NMS activity during the month • creating the quarterly reports for PCTs

  20. Evaluation of NMS • NMS will only be re-commissioned after March 2013 if the benefits of the service can be demonstrated • The data collected via the NMS module in PharmaBase will support the evaluation of the service • The Department of Health are currently selecting an academic team to evaluate NMS

  21. What do you need to do now? • Ensure you are accredited to provide MUR’s and have a consultation room fit for purpose. • Read the service specification and the Directions • Read the PSNC/NHS Employers guidance • Read the CPPE open learning programme • Use the other CPPE and alternative learning resources as needed • Attend a local workshop on NMS (where available) The final version of the service spec was published in Oct

  22. What do you need to do now? • Complete the pharmacist self-assessment form and a CPD record or two… • Develop an SOP (templates are available e.g NPA) • Train your pharmacy team on the service • With your support team, plan how the service will operate in your pharmacy • Familiarise yourself with the data recording requirements and paperwork

  23. What do you need to do now? • Discuss the service with your local GP practice teams (working with your LPC where appropriate) – briefing documents are available on the PSNC website • Familiarise yourself with the PharmaBase module or software provided by your PMR system. • Notify your PCT when you are ready to start providing the NMS • Claim your £750 Implementation payment once you have completed 6 NMS (a form to do this is on the PSNC website and must be submitted by 31st March) PCT notification form can be downloaded from www.psnc.org.uk/nms

  24. Information Sources • Chemist and Druggist website: http://www.chemistanddruggist.co.uk/nms • RPS website: http://www.rpharms.com/nhs-community-pharmacy-contract-england/new-medicine-service.asp • PSNC website: www.psnc.org.uk/nms • NPA website: http://www.npa.co.uk/NMS • Your LPC website or LPC contact. This hand-out has been adapted from one available on the PSNC website. A full Version can be found at: www.psnc.org.uk/nms

More Related